Loading data for PFE — first visit, this takes a few seconds.
Pfizer Inc. (PFE)
NYSE: PFE
· Real-Time Price · USD
28.30
-0.27 (-0.95%)
At close: Aug 27, 2026, 9:55 AM
The price, the headline numbers and the latest news, in one place.
Pfizer Inc. (PFE) Stock Price, Analysis & Data
-0.95% (1D)
| Bid | 28.32 |
| Market Cap | 160.05B |
| Revenue (ttm) | 63.7B |
| Net Income (ttm) | 4.34B |
| 0.28 | |
| 0.76 | |
| 36.95 | |
| 9.7 | |
| P/B (ttm) | 1.88 |
| P/S (ttm) | 2.51 |
| Earnings Date | Nov 3, 2026 |
| Ask | 28.27 |
| Volume | 35,017,573 |
| Avg. Volume (20D) | 42,362,103 |
| Open | 28.44 |
| Previous Close | 28.57 |
| Day's Range | 28.14 - 28.49 |
| 52-Week Range | 23.58 - 28.75 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | $1.72 (6.08%) |
| Ex-Dividend Date | Jul 24, 2026 |
About PFE
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, N...
Industry Drug Manufacturers - General
Sector Healthcare
IPO Date Jun 1, 1972
Employees 75,000
Stock Exchange NYSE
Ticker Symbol PFE
Website https://www.pfizer.com
Financial Performance
In 2025, Pfizer's revenue was 62.58B, a decrease of -1.65% compared to the previous year's 63.63B. Earnings were 7.77B, a decrease of -3.24%.
Financial StatementsEarnings Surprise
Pfizer has released their quarterly earnings on Aug 4, 2026:
- Revenue of $15.03B misses estimates by $0, with 2.60% YoY growth.
- EPS of 0.77 exceeds estimates by 0.09, with -1.28% YoY decline.
Pfizer Inc. is scheduled to release its earnings on Nov 3, 2026, before market opens.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
20 hours ago · Motley Fool
My 2 Favorite Dividend Stocks to Buy in AugustThese are two stocks that pay investors a regular income.
Page 1 of 2